The Johns Hopkins Bayview Medical Center PGY-1 Pharmacy Residency Program builds on Doctor of Pharmacy (Pharm.D.) education to contribute to the development of highly trained clinical pharmacists, eligible for board certification and for postgraduate year two (PGY-2) pharmacy residency training.
The program is customized for each resident based on his or her goals, interests and experience, and offers three distinct learning experiences throughout the 12-month program: required, elective and longitudinal experiences.
One calendar month in length unless otherwise noted
- Critical Care
- Infectious Diseases
- Internal Medicine
- Elective rotation within The Johns Hopkins Health System
- Ambulatory Care
- Integrated Pharmacy Practice Management (2 month, block experience)
- Medication Safety (3 month longitudinal experience)
One calendar month in length unless otherwise noted. Off-site rotations at The Johns Hopkins Hospital and other Hopkins entities also are available.
- Burn and Surgical Critical Care
- Cardiology and Cardiac Intensive Care Unit (CICU)
- Emergency Medicine
- Inpatient Palliative Care
- Investigational Drug Services
- Maternal Child Health and Neonatal Intensive Care Unit (NICU)
- Medication Safety
- Medicine Intensive Care Unit (MICU)
- Neurosciences and Neuro Critical Care Unit (NCCU)
- Outpatient Parenteral Antimicrobial Therapy (OPAT)
- Transitions of Care
Required throughout 12-month program.
- IRB-Approved MUE Research Project
- Pharmacy Practice and Staffing
- Code response
- Community service
- Pharmacotherapy rounds, ACPE-accredited continuing education
- Teaching in multidisciplinary teams and at the University of Maryland School of Pharmacy
- Teaching certificate programs
- Precepting pharmacy students
- Participation in professional organizations
The resident must be a United States citizen or permanent resident, or, for non-residents, must hold an F1 visa with 12 months of Optional Practical Training (OPT) work permit.
Graduated with a Doctor of Pharmacy degree from an accredited school of pharmacy, or, for foreign graduates, must have received Foreign Pharmacy Graduate Examination Committee (FPGEC) certification.
Residents are required to become a licensed pharmacist in the State of Maryland preferably by August 1, but no later than September 1.
Benefits and Compensation
- ACLS/BLS training
- Competitive salary
- Competitive retirement package
- Full medical, dental and vision benefits
- Paid time off with holidays
- Professional development through JHHS and other regional experiences
- Professional memberships
- Travel expenses for ASHP Mid-year and the Eastern States Conference
- Wellnet programs
Javier Vázquez, Pharm.D., MS, director of pharmacy at Johns Hopkins Bayview Medical Center, earned a doctorate of pharmacy degree from the University of Puerto Rico’s School of Pharmacy. Upon graduation, he pursued a master's of science degree at The Ohio State University in Health-System Pharmacy Administration (HSPA). During that time, he also completed PGY1 and PGY2 HSPA residencies at Grant Medical Center in Columbus, Ohio.
Dr. Vázquez serves as a pharmacist faculty member and coordinator for the Bernard J. Dunn School of Pharmacy at Shenandoah University. He is a preceptor for APPE students and PGY1 residents in practice management rotations, as well as for PGY1 and PGY2 HSPA residents from the Johns Hopkins Hospital completing elective rotations as Johns Hopkins Bayview Medical Center. Additionally, serves as commissioner of the Maryland Board of Pharmacy representing the acute care setting.
Bryna Delman Ewachiw, Pharm.D., BCOP, oncology pharmacy coordinator at Johns Hopkins Bayview, earned a bachelor's and doctorate of pharmacy degree from Temple University School of Pharmacy in Philadelphia, Pennsylvania. She has practiced in the field of oncology for over 15 years, among the top cancer programs in the region at The University of Maryland Medical Center and The Johns Hopkins Hospital. She holds clinical interests in supportive care, geriatric oncology and improving patient outcomes as a member of the oncology multi-disciplinary team.
Dr. Ewachiw also serves as clinical assistant professor at University of Maryland School of Pharmacy. She precepts at Johns Hopkins Bayview Medical Center, Shenandoah University, Bernard J. Dunn School of Pharmacy, and Notre Dame of Maryland University.
Additionally, Dr. Ewachiw is active in both the Hematology and Oncology Pharmacists’ Association (HOPA) and the Maryland Society of Health-System Pharmacists (MSHP).
Haley Fribance, Pharm.D, is a Clinical Pharmacy Specialist in Critical Care and Surgery at Johns Hopkins Bayview Medical Center. She earned her Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy and went on to complete a PGY1 Pharmacy Practice Residency and PGY2 Critical Care Residency at The Johns Hopkins Hospital. Dr. Fribance's clinical interests include sedation and agitation, shock syndromes, infectious diseases, and emergency medicine. She is a member of the Society of Critical Care Medicine (SCCM) and the American Society of Health-System Pharmacists (ASHP).
Elaine Liu, Pharm.D. is an infectious diseases and antimicrobial stewardship clinical pharmacy specialist at Johns Hopkins Bayview Medical Center. She earned her doctorate of pharmacy degree from Rutgers, The State University of New Jersey - Ernest Mario School of Pharmacy. Following graduation, she completed a PGY1 Pharmacy Residency at Jersey Shore University Medical Center in Neptune, New Jersey and then a PGY2 Infectious Diseases Pharmacy Residency at Hartford Hospital in Hartford, Connecticut. She is a member of The Society of Infectious Diseases Pharmacists (SIDP) and American College of Clinical Pharmacy (ACCP). Her passions include infective endocarditis, antimicrobial resistance mechanisms, and multidisciplinary education.
Mayrim Millan-Barea, PharmD, MBA, BCPS is the Assistant Director of Pharmacy Operations and Medication Use Systems at JHBMC. She earned her doctorate pharmacy degree from Notre Dame of Maryland University her Masters of Busdiness Administration degree from the Johns Hopkins Carey Business School. Mayrim completed a combined PGY1/2 Health System Pharmacy Administration and Leadership Residency at The Johns Hopkins Hospital.
Dr. Millan-Barea’s professional interests are academia, infectious diseases, employee professional development, data driven operational decision making, and drug shortage management. She serves as the Pharmacist Chair for the MSHP Pharmacy Technician Committee and precepts APPE students from Notre Dame of Maryland University School of Pharmacy, University of Maryland School of Pharmacy, and Shenandoah University. She also precepts PGY1 Residents at JHBMC and PGY2 Informatics Resident from The Johns Hopkins Hospital.
Jim Monolakis, Pharm.D. is the Manager for the Investigational Drug Service at Johns Hopkins Bayview Medical Center. He earned a Doctor of Pharmacy degree from the University of the Pacific, School of Pharmacy in Stockton, CA. After graduation, he completed a 2 year post-doctorate fellowship in critical care medicine and research at Hartford Hospital in Hartford, CT.
Dr. Monolakis is active within the institution managing the Investigational Drug Service along with a Research Pharmacy for the Johns Hopkins University, Department of Psychiatry in substance abuse research. Additionally, as a member of the Pharmacy & Therapeutics Committee, Dr. Monolakis is the liaison to the Johns Hopkins School of Medicine’s Institutional Review Board and is the primary preceptor for the Investigational Drug Service elective rotation. He is also a member of MSHP. His interests include pain management, infectious diseases, critical care pharmacy along with student and resident education.
Finnella Morgan, Pharm.D. is an emergency medicine clinical pharmacy specialist at Johns Hopkins Bayview Medical Center. She earned her doctorate of pharmacy degree at Albany College of Pharmacy and Health Sciences. Afterwards, she completed her PGY-1 pharmacy practice residency at Howard University Hospital in Washington, DC followed by her PGY-2 in emergency medicine at Maimonides Medical Center in Brooklyn, NY.
Her interests include resuscitation, toxicology and neurologic emergencies. She is a member of ASHP and ACCP.
Donald Singh, Pharm.D., MBA, BCPS, Medication Safety Coordinator at Johns Hopkins Bayview Medical Center, earned his doctorate of pharmacy and master of business administration degrees from the University at Buffalo in Buffalo, New York. He completed a PGY1 pharmacy residency at Kingsbrook Jewish Medical Center in Brooklyn, New York, followed by a PGY2 medication-use safety and policy residency at The Johns Hopkins Hospital in Baltimore, Maryland.
Dr. Singh co-chairs the Medication Event Review and Intervention Team and is actively involved in several other committees and workgroups including the Pharmacy and Therapeutics Committee and Controlled Substance Committee, among many others. Dr. Singh serves as a preceptor for APPE students and pharmacy residents in medication safety rotations.
Charlie Twilley, Pharm.D., MBA, is a clinical specialist in ambulatory medicine/anticoagulation management. He earned a doctorate of pharmacy from the University of Maryland and an MBA at the University of Baltimore. He has worked at the University of Maryland Medical Center and the Johns Hopkins Bayview Medical Center.
In addition to serving as a clinical assistant professor at the University of Maryland and precepting at the College of Notre Dame in Maryland, Dr. Twilley also precepts ambulatory care medicine and drug information & policy for the PGY-1 Residency Program at Johns Hopkins Bayview Medical Center.
Jillian Walters, Pharm.D, MPH is an infectious diseases and antimicrobial stewardship clinical pharmacy specialist at Johns Hopkins Bayview Medical Center. She earned her Doctor of Pharmacy and Master of Public Health degrees at Samford University in Birmingham, Alabama. After graduation, she completed a PGY-1 Pharmacy Residency at Johns Hopkins Bayview Medical Center and a PGY-2 Infectious Diseases Pharmacy Residency at the University of Mississippi Medical Center in Jackson, Mississippi.
She is a member of the Society of Infectious Diseases Pharmacists (SIDP), the American College of Clinical Pharmacy (ACCP), and the American Society of Health-System Pharmacists (ASHP). Her professional interests include antimicrobial resistance mechanisms, gram-negative bloodstream infections, and antimicrobial stewardship based quality improvement.
Colleen Whyte, Pharm.D., BCCCP is a clinical specialist in neurosciences and neurocritical care. She earned a doctorate of pharmacy degree from Concordia University – Wisconsin School of Pharmacy in Mequon, WI. After graduation, she completed a PGY-1 pharmacy residency at Aurora Health Care in Milwaukee, WI and PGY-2 residency in critical care at Christiana Hospital in Newark, DE. She is active within the institution in a variety of committees, as well as a member of ASHP, MSHP, SCCM, and NCS. Her interests include status epilepticus, meningitis/encephalitis, transitions of care, and student/resident education.
Henry Yeh, Pharm.D., BCCCP, is a graduate of the University of Maryland, Baltimore School of Pharmacy and completed residency training at West Virginia University Medical Center.
Dr. Yeh has been a clinical pharmacy specialist since beginning his career at Johns Hopkins Bayview after his residency. He is responsible for patient care activities in the Medical Intensive Care Unit and has been involved with many quality improvement initiatives. He continues to work on departmental projects in many areas throughout the Medical Center.
Dr. Yeh is the primary preceptor for the MICU rotation for the PGY1 program and is committed to teaching residents, nurses and providers on various critical care topics. He also serves as the pharmacy representative for the MICU and technology committees, and has been responsible for developing and reviewing protocols for sepsis, insulin management and improving patient care with technology. Dr. Yeh has been recognized by the MICU and CICU staff for his commitment to patient care.